a | 1A | Latency to eat in NSF | Normal distribution | ANOVA | p = 0.0052 |
b | 1A | Latency to eat in NSF (0 vs 10 mg/kg) | Normal distribution | Holm–Sidak post hoc test | p = 0.0042 |
c | 1B | Immobility, main effect of treatment | Normal distribution | 2-way repeated measures ANOVA | p < 0.0001 |
d | 1B | Immobility, main effect of time | Normal distribution | 2-way repeated measures ANOVA | p = 0.0003 |
e | 1B | Immobility, treatment × time interaction | Normal distribution | 2-way repeated measures ANOVA | p = 0.9980 |
f | 1B | Immobility, ketamine vs saline | Normal distribution | Holm–Sidak post hoc test | p < 0.0001 |
g | 3A | Short-term effects on cell maturation | Normal distribution | t test | p = 0.0375 |
h | 3B | Proliferation effects | Normal distribution | t test | p = 0.0359 |
i | 3D | Maturation effects in younger cells | Normal distribution | t test | p = 0.3548 |
j | 3F | Very rapid maturation effects | Normal distribution | t test | p = 0.0450 |
k | 3G | Strong NeuN expression | Normal distribution | t test | p = 0.0062 |
l | 4C | Long-term 14 d maturation effects | Normal distribution | t test | p = 0.0108 |
m | 4D | Long-term 21 d maturation effects | Normal distribution | t test | p = 0.0181 |
n | 4E | Long-term 14 d proliferation effects | Normal distribution | t test | p = 0.9726 |
o | 4F | Long-term 21 d proliferation effects | Normal distribution | t test | p = 0.365 |
p | 4G | Long-term 14 d survival effects | Normal distribution | t test | p = 0.3280 |
q | 4H | Long-term 21 d survival effects | Normal distribution | t test | p = 0.0191 |
r | 5A | Sustained maturation, main effect of CORT | Normal distribution | 2-way ANOVA | p = 0.9964 |
s | 5A | Sustained maturation, main effect of ketamine | Normal distribution | 2-way ANOVA | p = 0.0017 |
t | 5A | Sustained maturation, CORT × ketamine interaction | Normal distribution | 2-way ANOVA | p = 0.9821 |
u | 5B | Proliferation, main effect of ketamine | Normal distribution | 2-way ANOVA | p = 0.0130 |
v | 5B | Proliferation, main effect of CORT | Normal distribution | 2-way ANOVA | p = 0.0091 |
w | 5B | Proliferation, CORT × ketamine interaction | Normal distribution | 2-way ANOVA | p = 0.9883 |
x | 5D | Sucrose preference | Normal distribution | ANOVA | p = 0.0072 |
y | 5D | Sucrose preference, vehicle/saline vs CORT/saline | Normal distribution | Holm-Sidak post hoc test | p = 0.0074 |
z | 5D | Sucrose preference, CORT/saline vs CORT/ketamine | Normal distribution | Holm-Sidak post hoc test | p = 0.0405 |
aa | 5E | Survival | Normal distribution | ANOVA | p = 0.3512 |
bb | 6D | DCX+ cell number, main effect of genotype | Normal distribution | 2-way ANOVA | p < 0.0001 |
cc | 6D | DCX+ cell number, main effect of ketamine | Normal distribution | 2-way ANOVA | p = 0.2393 |
dd | 6D | DCX+ cell number, genotype × ketamine interaction | Normal distribution | 2-way ANOVA | p = 0.2477 |
ee | 6E | Latency to eat in NSF, main effect of genotype | Normal distribution | 2-way ANOVA | p = 0.6008 |
ff | 6E | Latency to eat in NSF, main effect of ketamine | Normal distribution | 2-way ANOVA | p = 0.0016
|
ee | 6E | Latency to eat in NSF, genotype × ketamine interaction | Normal distribution | 2-way ANOVA | p = 0.5469 |